Applying Experiences from Trials of Bacille Calmette-Guérin Vaccine
Open Access
- 1 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (Supplement) , S262-S265
- https://doi.org/10.1086/313886
Abstract
Bacille Calmette-Guérin (BCG) vaccine, a live vaccine developed to prevent tuberculosis (TB), has been given to billions of persons over more than 7Keywords
This publication has 27 references indexed in Scilit:
- Protection from Mycobacterium avium Complex Disease in Human Immunodeficiency Virus-Infected Persons with a History of TuberculosisThe Journal of Infectious Diseases, 1996
- Alteration of the immune response to Mycobacterium bovis BCG in mice exposed chronically to low doses of UV radiationCellular Immunology, 1990
- Mycobacterial diseasesThe Lancet, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- Neonatal bcg vaccination and mycobacterial cervical adenitis in childhoodTubercle, 1987
- Clinical Significance of Nontuberculous Mycobacteria: A Bacteriological Survey of Swedish Strains isolated between 1973 and 1981Scandinavian Journal of Infectious Diseases, 1986
- A possible link between vitamin d deficiency and impaired host defence to mycobacterium tuberculosisTubercle, 1985
- The protective effect of BCG vaccination as indicated by autopsy studiesTubercle, 1979
- IDENTIFICATION OF THE TUBERCULOUS‐INFECTED BY SKIN TESTS*Annals of the New York Academy of Sciences, 1968
- The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccinesTubercle, 1967